Effects of Oral Iron(III) Hydroxide Polymaltose Complex Supplementation on Hemoglobin Increase, Cognitive Function, Affective Behavior and Scholastic Performance of Adolescents with Varying Iron Status

Pallaki Baby Devaki; Ranjit K Chandra; Peter Geisser

doi:10.1055/s-0031-1296401

Arzneimittelforschung, Inhaltsverzeichnis

Arzneimittelforschung 2009; 59(6): 303-310
DOI: 10.1055/s-0031-1296401

Therapeutics for States of Deficiency

Editio Cantor Verlag Aulendorf (Germany)

Effects of Oral Iron(III) Hydroxide Polymaltose Complex Supplementation on Hemoglobin Increase, Cognitive Function, Affective Behavior and Scholastic Performance of Adolescents with Varying Iron Status

A single centre prospective placebo controlled study

Authors

Pallaki Baby Devaki

¹Department of Home Science, Sri Venkateswara University, Tirupati, AP, (India)
Ranjit K Chandra

²Allergy, Asthma and Immunology Center, Gurgaon, Haryana, (India)
Peter Geisser

³Vifor (International) Inc. Pharmaceutical Products, St. Gallen, (Switzerland)

Abstract

Objective:

To assess the effects of iron supplementation on iron status, cognitive function, affective behavior and scholastic performance in adolescents with varying iron status.

Methods:

Adolescents of both sexes with varying iron status were allocated to four treatment groups by using inclusion criteria. Three of the four groups (iron deficient anemic, iron deficient and control supplement) received iron(III) hydroxide polymaltose complex (IPC, Mal-tofer^®) containing 100 mg of elemental iron 6 days a week for 8 months, while the fourth group (control placebo) was given a placebo. Hematological parameters, cognitive function, affective behavior and scholastic performance were assessed at baseline, 4 months and 8 months of supplementation.

Results:

Cognitive and scholastic performance test scores for the three supplemented groups increased from baseline to 4 months and from 4 months to 8 months (with concomitant increases in hematological parameters), whereas no increase was observed in the placebo group. No increase was seen in affective behavior scores for any of the groups during or after supplementation.

Conclusions:

IPC supplementation for eight months yielded significant improvements in cognitive function and scholastic performance in Indian adolescents with and without iron deficiency and anemia.

Key words

Adolescents - Anemia - Antianemic drugs - Cognition - Iron deficiency - Iron(III) hydroxide polymaltose complex - Maltofer®

Volltext

Referenzen

References
1 DeMayer E, Aaiels-Tegman M. The prevalence of anemia in the world. World Health Statistics Quarterly. 1985; 138: 302-316
2 Cook JD. Iron deficiency anaemia. Baillières Clin Haematol. 1994; 7 (4) 787-814
3 Cook J. Finch C. Assessing iron status of a population. Am J Clin Nutr. 1979; 32: 2115-19
4 Halterman JS, Kaczorowski JM, Aligne CA, Auinger P, Szila-gyi PG. Iron deficiency and cognitive achievement among school-aged children and adolescents in the United States. Pediatrics. 2001; 107: 1381-1386
5 Krishna Swamy KR, Sarma R. Health and nutritional status of women and adolescent girls in India in empowerment of women with special reference to women’s health Workshop by National Commission for Women. Tirupati (India): S. V. University; 2000: 47-58
6 Kurz KM, Johnson-Welch C. The nutrition and lives of adolescents in developing countries: findings from the nutrition of adolescent girls research programme. Washington, DC: International Center for Research on Women [ICRW]; 1994: 34 p.
7 Voluntary Health Association of India (VHAI). 2005 Available from: http:www.pfzerindia.com/caring-healthcare.html
8 Survival for Women and Children (SWACH) Foundation. Anemia in pregnant women and adolescent girls in Haryana. India Quarterly Progress Report; April to June 1997 Submitted Mother Care Project, Johnsnow, Inc.
9 De Maeyer, Dallman P, Gurney JM, Hallberg L, Sood SK Srikantia. Preventing and controlling iron deficiency anemia through primary health care. Geneva: World Health Organization. 1989;
10 Horton S, Ross J. The economics of iron deficiency. Food Policy. 2003; 28 (1) 51-75
11 Felt BT, Lozoff B. Brain iron behaviour of rats are not nor-malized by treatment of iron deficiency anemia during early development. J Nutr. 1996; 126: 693-701
12 Hallberg L, Hutten L, Lindstedt G, Lundberg P, Mark A, Purens J et al Prevalence of iron deficiency in Swedish adolescents. Pediatr Res. 1993; 34: 680-87
13 Seshadri S, Gopaldas T. Impact of iron supplementation and cognitive functions in preschool and school-aged children: The Indian experience. Am J Clin Nutr. 1989; 50: 675-86
14 Geisser P. Iron therapy with special emphasis on oxidative stress. Rorschach. Switzerland: Löpfe-Benz AG;; 1998
15 Crichton RR, Danielson BG, Geisser P. Iron therapy with special emphasis on intravenous administration. 4th ed Bremen (Germany): UNI-MED; 2008
16 Jacobs P, Wood L, Bird AR. Better Tolerance of Iron Poly-maltose Complex Compared with Ferrous Sulphate in the Treatment of Anaemia. Hematology. 2000; 5: 77-83
17 Tuomainen TP, Nyyssonen K, Porkkala-Sarataho E, Salo-nen R, Baumgartner JA, Geisser P et al Oral supplementation with ferrous sulfate but not with non-ionic iron poly maltose complex increases the susceptibility of plasma lipoproteins to oxidation. Nutr Res. 1999; 19: 1121-32
18 Langstaff RJ, Geisser P, Heil WG, Bowdler JM. Treatment of iron-deficiency anemia: a lower incidence of adverse effects with Ferrum Hausmann than ferrous sulfate. Brit J Clin Res. 1993; 4: 191-8
19 Jacobs P, Johnson G, Wood L. Oral iron therapy in human subjects comparative absorption between ferrous salts and iron polymaltose. J Med. 1984; 15: 367-72
20 Jacobs P, Wormald LA, Gregorg MC. Absorption of iron polymaltose and ferrous sulphate in rats and humans. S Afr Med J. 1979; 55: 1065-72
21 Geisser P. Safety and efficacy of iron(III)-hydroxide polymaltose complex. Arzneimittelforschung. 2007; 57: 439-52
22 Devaki PB, Chandra RK, Geisser P. Effect of oral supplementation with iron(III)-hydroxide polymaltose complex on the immunological profile of adolescents with varying iron status. Arzneimittelforschung. 2007; 57: 417-25
23 Devaki PB, Chandra RK, Geisser P. Effects of Oral Supplementation with Iron(III) Hydroxide Polymaltose Complex on the Hematological profile of Adolescents with Varying Iron Status: A single centre prospective placebo controlled study. Arzneimittelforschung. 2008; 58: 389-97
24 Manual of Laboratory Techniques National Institute of Nutrition (NIN). Ind C Med Res. 1983; 1435
25 National Psychological Corporation Catalogue of psychological books and tests instruments and experimental materials (2002–2003). Agra (India): Bhargava bhavan;
26 Ramalingaswamy P. Weschler Adult Performance Intelligence scale form-PR. Manual of Indian adaptation of WAIS performance scale; 1974
27 BarOn R, Parker JDA. BarOn Emotional Quotient Inventory: Youth Version (EQ-i:YV). Toronto (Canada): Multi-Health Systems; 2000
28 Pollitt Ε, Hathinat Ρ, Kotchabhakdi NJ, Missell L, Valyasevi A. Iron deficiency and educational achievement in Thailand. Am J Clin Nutr. 1989; 50 (s3) 687-97
29 Sailaja C. School going adolescents (1316 years); prevalence of iron deficiency and anemia, nutrient intake and the effect of iron deficiency anemia on vigilance task performance [dissertation]. Tirupati (India): S. V. University; 1991
30 Webb TE, Oski FA. Iron deficiency anemia and scholastic achievement in young adolescents. J Pediatr. 1973; 82: 827-30
31 Webb TE, Oski FA. Iron deficiency anemia and scholastic achievement, behaviour stability and perceptual sensitivity to adolescents. Pediatr Res. 1973; 7: 294 (abstract)
32 Soemantri AG, Pollitt E, Kim I. Iron deficiency anemia and educational achievement. Am J Clin Nutr. 1985; 42: 1221-8
33 Pollitt E, Soemantri AG, Yunis F, Scrimshaw NS. Cognitive effects of iron deficiency anemia. Lancet. 1985; 1: 158
34 Pollitt E, Leibel RL, Greenfield DB. Iron deficiency and cognitive test performance in preschool children. Nutr Beha-vou. 1983; 1: 137-46
35 Halterman JS, Kaczorowski JM, Aligne CA, Auinger Ρ, Szila-gyi PG. Iron deficiency and cognitive achievement among school-aged children and adolescents in the United States. Pediatrics. 2001; 107: 1381-6
36 Webb TE, Oski FA. Behavioural status of young adolescents with iron deficiency anemia. J Spec Edu. 1974; 8: 153-6
37 Dallman PR, Siimes MA, Manies EC. Brain iron: Persistent deficiency following short-term iron deprivation in the rat. Br J Haem. 1975; 31: 209-15
38 Dallman PR, Spirito RA. Brain iron in the rat. Extremely slow turnover in normal rats may explain long- lasting effects of early iron deficiency. J Nutr. 1997; 107: 1075-81
39 Youdim MBH, Green AR, Aronson JK. The implications of the effects of tissue iron deficiency on behaviour and drug metabolism. In: Pitcher CS, Richardson RG. editors. Anaemia in general practice. The place of haematinics. Maidenhead (UK): Abbott Laboratories Ltd.; 1977: 37-42
40 Mackler B Perxon, Miller LR. Iron deficiency in the rat; biochemical studies on iron metabolism. Pediatr Res. 1978; 12: 217-20
41 Shukla A, Agarwal KN, Chansuria JPN, Taneja V. Effect of latent iron deficiency on 5hydroxy tryptanine metabolism in rat brain. J Neuro Chem. 1989; 52: 730-34
42 Youdim MBH, Green AR, Bloomfield MR, Mitchell BD, Heals DJ, Grahame Smith DG. The effect of iron deficiency on brain biogenic monoamine biochemistry and functions. Neuropharmacology. 1980; 19: 259-67
43 Yehuda S, Youdim MBH. Brain iron deficiency: biochemistry and behaviour. In: Brain iron: neuro chemical and behavioural aspects. Youdim MBH. (editor) London: Taylor and Francis; 1988: 89-114
44 Youdim MBH, Shachar DP, Yehuda S. Putative biological mechanisms of the effect of iron deficiency on brain biochemistry and behaviour. Am J Cli Nutr. 1989; 50: 607-15
45 Hallgren B, Sourander P. The effect of age on the non-heme iron in human brain. J Neuro Chem. 1958; 3: 41-51
46 Youdim MBH, Yehuda S, BenUriah Y. Reversed circadian rhythm of dopaminergic-mediated behaviours and thermoregulation in rats produced by iron deficiency. Eur J Pharmacol. 1981; 4: 295-301
47 Ben-Shachar D, Ashkenazi R, Youdim MBH. Longterm consequences of early iron-deficiency on dopaminergic neuro-transmission. Int J Develop Neurosci. 1986; 4: 81-8
48 Iversen SD. Brain dopamine systems and behaviour. In Iversen LI, Iversen SD, Snyder SH. editors Handbook of Psycho-pharmacology. Vol. 8. Drugs, Neuro-transmitters and Behaviour. New York: Plenum Press; 1977. p. 333-84
49 Youdim MBH, Yehuda S, BenShachar D, Ashkenazi R. Behavioural and brain biochemical changes in iron deficient rats; Involvement of iron dopamine receptor function. In: Pollitt E, Leibel L. editors Iron deficiency Brain Biochemistry and Behaviour. New York: Raven Press; 1982: 39-56
50 Kaladhar M, Narasinga Rao BS. Effects of iron deficiency on serotonin uptake in vitro by rat brain synaptic vesicles. J Neuro Chem. 1982; 38: 1576-81
51 Webb TH, Krill CE, Oski FA, Tsou K. Relationship of iron status to urinary norepinephrine excretion in children 7–12 years of age. J Pediatr Gastroenterol Nutr. 1982; 1: 207-9
52 Wagner A, Fortier N, Giroux A, Lukes J, Snyder LM. Catecholamines in adult iron deficiency patients. Experientia. 1979; 35: 681-2
53 Vorhees LM, Stuart MJ, Stockman JA, Oski FA. Iron deficiency anemia and increased urinary norepinephrine excretion. Pediatrics. 1975; 86: 542-7
54 Hastings JE, Barkley RA. A review of psychophysiological research with hyperkinetic children. J Abn Child Psychol. 1978; 6: 413-47
55 Callender ST. Treatment of iron deficiency. Clin Hematol. 1982; 11: 327
56 Robotham JL, Lietman PS. Acute iron poisoning. A review. Am J Dis Child. 1980; 134: 875